✦ LIBER ✦

A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

✍ Scribed by Dispenzieri, A; Wiseman, G A; Lacy, M Q; Litzow, M R; Anderson, P M; Gastineau, D A; Tefferi, A; Inwards, D J; Micallef, I N M; Ansell, S M; Porrata, L; Elliott, M A; Lust, J A; Greipp, P R; Rajkumar, S V; Fonseca, R; Witzig, T E; Erlichman, C; Sloan, J A; Gertz, M A

Book ID: 110056098
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 171 KB
Volume: 19
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2403575

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II study of 153Sm-EDTMP and high

A Phase II study of 153Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

✍ Angela Dispenzieri; Gregory A. Wiseman; Martha Q. Lacy; Suzanne R. Hayman; Shaji 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

Phase I–II evaluation of rapid sequence

Phase I–II evaluation of rapid sequence tandem high-dose melphalan with peripheral blood stem cell support in patients with multiple myeloma

✍ Weaver, C H; Zhen, B; Schwartzberg, L S; Leff, R; Magee, M; Geier, L; Deaton, K; 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 61 KB

A phase I–II study of high-dose melphala

A phase I–II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma

✍ Weaver, C H; Greco, F A; Hainsworth, J D; Zhen, B; Baldwin, P; Wittlin, F; Lewis 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB

High-dose idarubicin, cyclophosphamide a

High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised study

✍ R. Fenk; P. Schneider; M. Kropff; A. N. Huenerlituerkoglu; U. Steidl; C. Aul; B. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

High-dose mitoxantrone + melphalan (MITO

High-dose mitoxantrone + melphalan (MITO/L-PAM) as conditioning regimen supported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicity

✍ Tarella, C; Zallio, F; Caracciolo, D; Cuttica, A; Corradini, P; Gavarotti, P; La 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 134 KB

Analysis of circulating tumor cells in p

Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation

✍ Kiel, K; Cremer, F W; Rottenburger, C; Kallmeyer, C; Ehrbrecht, E; Atzberger, A; 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB